Biblio
2023
Xu C, Huang KKyon, Law JHao, Chua JShijia, Sheng T, Flores NM, Pizzi MPool, Okabe A, Tan ALay Keng, Zhu F, et al. Comprehensive molecular phenotyping of -deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities. Gut. 2023.
2022
Ho SWei Ting, Sheng T, Xing M, Ooi WFong, Xu C, Sundar R, Huang KKyon, Li Z, Kumar V, Ramnarayanan K, et al. Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities. Gut. 2022.
2020
Xing M, Ooi WFong, Tan J, Qamra A, Lee P-H, Li Z, Xu C, Padmanabhan N, Lim JQuan, Guo YAmanda, et al. Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer. J Clin Invest. 2020.